Literature DB >> 28058208

Quantitative EEG in attention-deficit/hyperactivity disorder: A companion payment policy review for clinicians and payers.

Marc R Nuwer1, Jeffrey Buchhalter1, Katie M Shepard1.   

Abstract

Quantitative EEG measurement of the scalp vertex theta/beta ratio (TBR) is marketed as a tool for use in the evaluation of patients who may have attention-deficit/hyperactivity disorder (ADHD). The American Academy of Neurology (AAN) recently assessed the literature about this tool. The assessment urged caution, considering that the TBR remains an investigational research tool at this time. This perspective comments further on that assessment and its rationale, and recommends a perspective for the clinician and payer.

Entities:  

Year:  2016        PMID: 28058208      PMCID: PMC5200849          DOI: 10.1212/CPJ.0000000000000308

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  12 in total

1.  EEG aspects in the diagnosis and treatment of minimal brain dysfunction.

Authors:  J H Satterfield; L I Lesser; R E Saul; D P Cantwell
Journal:  Ann N Y Acad Sci       Date:  1973-02-28       Impact factor: 5.691

2.  Using brain-based cognitive measures to support clinical decisions in ADHD.

Authors:  Leanne M Williams; Daniel F Hermens; Thida Thein; C Richard Clark; Nicholas J Cooper; Simon D Clarke; Chris Lamb; Evian Gordon; Michael R Kohn
Journal:  Pediatr Neurol       Date:  2010-02       Impact factor: 3.372

3.  Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  David Gloss; Jay K Varma; Tamara Pringsheim; Marc R Nuwer
Journal:  Neurology       Date:  2016-10-19       Impact factor: 9.910

4.  The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: reliability and validity studies.

Authors:  V J Monastra; J F Lubar; M Linden
Journal:  Neuropsychology       Date:  2001-01       Impact factor: 3.295

5.  Resting electroencephalogram in attention deficit hyperactivity disorder: developmental course and diagnostic value.

Authors:  Inez Buyck; Jan R Wiersema
Journal:  Psychiatry Res       Date:  2014-01-11       Impact factor: 3.222

6.  Relation between resting EEG to cognitive performance and clinical symptoms in adults with attention-deficit/hyperactivity disorder.

Authors:  Martine van Dongen-Boomsma; Marieke M Lansbergen; Evelijne M Bekker; J J Sandra Kooij; Maurits van der Molen; J Leon Kenemans; Jan K Buitelaar
Journal:  Neurosci Lett       Date:  2009-11-27       Impact factor: 3.046

7.  Editorial Perspective: How should child psychologists and psychiatrists interpret FDA device approval? Caveat emptor.

Authors:  Martijn Arns; Sandra K Loo; M Barry Sterman; Hartmut Heinrich; Jonna Kuntsi; Philip Asherson; Tobias Banaschewski; Daniel Brandeis
Journal:  J Child Psychol Psychiatry       Date:  2016-05       Impact factor: 8.982

8.  Characterization of the theta to beta ratio in ADHD: identifying potential sources of heterogeneity.

Authors:  Sandra K Loo; Alexander Cho; T Sigi Hale; James McGough; James McCracken; Susan L Smalley
Journal:  J Atten Disord       Date:  2012-12-20       Impact factor: 3.256

9.  A decade of EEG Theta/Beta Ratio Research in ADHD: a meta-analysis.

Authors:  Martijn Arns; C Keith Conners; Helena C Kraemer
Journal:  J Atten Disord       Date:  2012-10-19       Impact factor: 3.256

10.  Integration of an EEG biomarker with a clinician's ADHD evaluation.

Authors:  Steven M Snyder; Thomas A Rugino; Mady Hornig; Mark A Stein
Journal:  Brain Behav       Date:  2015-03-05       Impact factor: 2.708

View more
  1 in total

1.  Comparison of Quantitative Electroencephalography between Tic Disorder and Attention-Deficit/Hyperactivity Disorder in Children.

Authors:  Ilju Lee; Jiryun Lee; Myung Ho Lim; Kyoung Min Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-11-30       Impact factor: 2.582

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.